

NDA’s & R
Review clin/pharm sections of NDA’s with R graphics/analyses
R in Clin pharm for nonlinear mixed effects modeling and subsequent graphical analysis
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208573Orig1s000ClinPharmR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209296Orig1s000ClinPharmR.pdf
https://channel9.msdn.com/Events/useR-international-R-User-conference/useR2016/Using-R-in-a-regulatory-environment-FDA-experiences
https://uupharmacometrics.github.io/xpose/
https://cran.r-project.org/web/views/ClinicalTrials.html
https://www.r-project.org/doc/R-FDA.pdf
https://github.com/andyofsmeg/RValidation
http://washstat.org/presentations/20181024/Schuette.pdf
The Role of R in Drug Discovery, Research, and Development https://rstudio.com/resources/webinars/the-role-of-r-in-drug-discovery-research-and-development/
